CompoAtlas

NEP pastilles Menthe Eucalyptus Acerola

Food supplement declared in France, declaration No 2019-6-422

NEP pastilles Menthe Eucalyptus Acerola, from LABORATOIRES NEPENTHES, is a food supplement declared in France. Status: withdrawn from the market on 3 July 2022. Main ingredients: Mentha x 64 mg per day, Malpighia glabra 59 mg per day, Eucalyptus globulus 12 mg per day, Huile de coprah. None of the rules we check flags an issue with its declared composition.

Brand
NEP
Food business operator placing the product on the market
LABORATOIRES NEPENTHES
Status
Withdrawn from the market on 3 July 2022
Form
Gummy
Daily dose
6
Directions for use
6 gommes par jour
Not recommended (according to the manufacturer)
Breastfeeding women, Pregnant women, Liver problems, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Respiratory tract

Declaration 295990, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Mentha x piperita L.Essence (sommités fleuries)Pression à froid64 mg
Malpighia glabra L.FruitExtrait sec aqueux59 mg
Eucalyptus globulus Labill.Essence (feuille)Pression à froid12 mg

Other active ingredients

NamePer day
Huile de coprahnot declared

Additives

E414, E420, E965, E903, E955

Other ingredients

menthol

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes et allaitantes et aux enfants de moins de 6 ans. » Pour la menthe poivrée : *Demandez conseil à un professionnel de santé en cas d'obstruction des voies biliaires(calculs), de reflux gastro-oesophagien, ou de troubles hépato-pancréatique. * Déconseillé en cas d'antécédents d'épilepsie, d'antécédents de convulsions ou d'antécédent de pathologies neurologiques. *Pas d'utilisation prolongée. Pour l’eucalyptus : * Déconseillé chez les moins de 12 ans en cas d'antécédent de convulsion.*Demandez conseil à un professionnel de santé en cas de traitement antiépileptique ou d'antécédent de convulsion. Ne pas dépasser un mois de prise. Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas dépasser la dose journalière conseillée. Tenir hors de portée des enfants.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Mentha x piperita L.
    Read the warning, when it applies and the studies cited

    PEPPERMINT - MENTHA X PIPERITA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Condition of application: Essential oil.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    Condition of application: Essential oil.

    When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (2)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : NEP

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “NEP pastilles Menthe Eucalyptus Acerola: composition and regulation”, https://compoatlas.com/en/supplements/products/295990-nep-pastilles-menthe-eucalyptus-acerola, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line